Surgery painkiller dose may predict chronic pain risk
NCT ID NCT06374849
First seen Nov 19, 2025 · Last updated May 15, 2026 · Updated 20 times
Summary
This study investigates if the dose of sufentanil, a strong painkiller given during planned abdominal surgery, is linked to chronic pain that lasts 3 months after the operation. Researchers will follow 855 adults having non-major abdominal surgery to measure pain levels and identify risk factors. The goal is to help doctors personalize anesthesia to reduce the chance of long-term pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Amiens-Picardie
Amiens, 80054, France
Conditions
Explore the condition pages connected to this study.